The Evidence Based Rheumatology Podcast
Health & Fitness:Medicine
Fun study this week from JAMA Network Open and the French Vasculitis Study Group. They used a target trial emulation (one of my favorites) to ask whether RTX > CYC in AAV (another one of my favorites). I tried to use this to compare between observational and randomized data.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2799018
E113: CAR-T is Coming to Rheumatology
E112: Gabapentin is Trash
E111: PEXIVAS Subsets with Mike Walsh & Mats Junek
E110: Rheum4Debate - Screening for RA-ILD with Joshua Solomon and Scott Matson
E109: Abatacept for Pre-RA - the ARIAA Study
E108: Myositis Guidelines for Cancer Screening w/Alexander Oldroyd
E107: Fragility of SLE Randomized Controlled Trials
E106: GCA/PMR with Bhaskar Dasgupta
E105: Autoimmunity Post COVID-19?
E104: Sarilumab for PMR - The SAPHYR Study
E103: Len Calabrese on Monoclonal Antibodies for COVID-19
E102: Unintentional Unblinding in Rheumatic Disease Trials
E101: Pred v Colchicine for CPPD: COLCHICORT
E100: ADVOCATE Health Related Quality of Life
E99: Hospital Problems
E98: Key Opinion Leaders & ILD Guidelines
E97: Does allopurinol reduce CVD? The ALLHEART Study
E96: Long COVID - Where to After Norway?
E94: Steroids and Psoriasis Flares
Create your
podcast in
minutes
It is Free
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Peter Attia Drive
The Doctor’s Farmacy with Mark Hyman, M.D.